Takeuchi et al. [60] reported that VE-822 reduced the expression of p-CHK1 in HEC-1-B and HEC-6 endometrial cancer cell lines, and combined with DXR, CDDP, or IR, significantly enhanced tumor cell killing, confirming its chemo/radiotherapy sensitization effect. This evidence concerns the gene CHEK1 and neoplasm.